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Summary A girl aged 6 years 9 months with severe 
heart disease secondary to hom~ygous 
familial hyper cholesterolaemia underwent orthotopic cardiac 
transplantation and her liver was replaced with the liver of the 
same donor. In the first 10 weeks after transplantation serum 
cholesterol fell to 270 mg/dl from preoperative 
concentrations of more than 1000 mg/dl. 
INTRODUCTION 
CARDIAC transplantation for end-stage heart disease would 
be futile in a patient with homozygous familial 
hypercholesterolaemia (FH) unless the metabolic processes 
responsible for the rapidly progressive atherosclerosis in such 
patients can be counteracted. We have attempted to meet this 
objective by orthotopic transplantation of the liver and heart 
from the same donor into a recipient with severe FR. 
CASE·REPORT 
On September I, 1983, a girl aged 6 years and 4 months was 
admitted for metabolic studies to the University of Texas 
Southwestern Medical School in Dallas. From the age of 3 months 
progressive xanthomas had developed on the contact areas of her 
buttocks and extremities. FH had been diagnosed when she was 6 
years old. Culture of cutaneous fibroblasts indicated that she had 
the deficiency oflow density lipoprotein (LDL) receptors which is 
typical of FH.l On admission, her plasma cholesterol was 1225 
mg/dl and her plasma triglyceride was 154 mg/dl. Liver function 
tests were normal arid she had no cardiac symptoms. 
However, angina pectoris quickly developed and she required a 
double coronary artery bypass. A portacaval shunt was suggested, 
but liver transplantation was viewed as a better way of reducing 
serum cholesterol. At this point recurrences of angina led to the 
performance of a second bypass operation: and when she could not 
be weaned from the heart-lung bypass because of mitral 
regurgitation caused by previous papillary muscle necrosis, the 
mitral valve was replaced. 
During late December, 1983, she had recurrent bouts of angina 
pectoris and heart failure. It was concluded that her heart disease 
had become too severe to permit liver transplantation, and for this 
reason concomitant heart replacement was suggested by the 
transplant team as the only realistic option. During late December, 
1983, and in early January, 1984,.this seemingly drastic proposal 
was considered and ultimate! y accepted by a consortium of 
physicians and surgeons from the Pennsylvania and Texas medical 
centres. There was approval by the Human Rights Institutional 
Review Board of the Children's Hospital of Pittsburgh. 
The heart and liver replacements were carried out on Feb 14, 
1984, during total cardiopulmonary bypass. Although the recipient 
was aged 6 years and 9 months, she weighed only 19.1 kg. Her 
blood type was A. The donor was a girl of 4 liz of 0 blood .type who 
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weighed 16.2 kg. There was a total donor/recipient mismatch at the 
HLA A, B, and DR loci. The technical details of this 16-hour 
operation will be reported separately (B. W. Shaw, Jr, personal 
communication). The removed heart had advanced atherosclerotic 
and valvular disease. The excised liver was normal by gross and 
microscopic examination. 
Good cardiac and hepatic function were achieved from the grafts. 
Cyclosporin and steroids were used as immunosuppressants.2 A 
persistent increase in serum bilirubin concentration 5 days after 
surgery suggested rejection but this subsided without an increase in 
immunosuppression. Standard liver function tests have been 
normal since the second postoperative week. Immunosuppression 
with 300 mg/day cyclosporin and 7· 5 mg/day prednisone is being 
continued. 
RESULTS 
Effects on Circulating Cholesterol and Triglycerides 
Serum or plasma cholesterol concentrations were 
determined in the Dallas and Pittsburgh laboratories with 
commercial kits that were based on an enzymatic assay 
principle.3 Differences between the results in the two 
laboratories in analysing plasma (Dallas) or serum 
(Pittsburgh) averaged less than 4%. Triglyceride analyses 
with enzymatic methods4 also yielded generally comparable 
results in the 2 laboratories but with a 15% variation. Plasma 
cholesterol and triglyceride concentrations of the donor were 
120 and 100 mg/dl, respectively, in the Dallas laboratory. 
During her stay on the metabolic ward in Dallas in 
September and October, 1983, the patient was in a 
lipoprotein turnover study. She was on an isocaloric formula! 
solid food diet containing 40% of calories as fat and less than 
300 mg of cholesterol per day. The patient's average 
cholesterol concentration (normal <195 mg/dl) was more 
than 1000 mg/dl and her total plasma triglycerides (normal 
< 150 mg/dl) were less strikingly raised (see figure). 
Within a few days of the heart-liver transplantation, serum 
cholesterol concentrations had fallen to less than a fourth of 
the pre-existing level, but as the patient recovered from the 
operation and began to eat, the values rose to above 300 mg/dl 
and then fell slowly to 268 mg/dl (fig). Triglyceride 
concentrations were increased in the first month but declined 
(figure) as the postoperative prednisone doses were decreased 
from 30 mg/day toward the present level of 7' 5 mg/day. 
The visible tendinocutaneous xanthomas have undergone a 
dramatic regression during the 10 weeks of follow-up. The 
lesions have flattened and have changed from yellow to pink. 
DISCUSSION 
FR is caused by a defect in the gene for the LDL receptor. 1 
Although the abnormality is common to all cells, the liver has 
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a central role in the resulting hypercholesterolaemia,5-7 and 
the possibility has been raised of treating the disease with 
liver transplantation. 8 The paucity ofLDL receptors in the 
hepatocytes of patients with FH has been thought to be the 
most important factor in the sluggish catabolism as well as in 
the heightened total body synthesis of LDL and 
cholesterol. 5-7 If this were true, provision of a normal liver 
would correct FH because transplanted hepatocytes retain 
their original metabolic specificity.2 
In our patient, the degree of correction has been 
substantial, at least as judged by serum cholesterol 
concentrations, but it has not been complete. Serum 
cholesterol is now about 270 mg/dl. Absorption of cholesterol 
from rapidly involuting xanthomatous deposits may be 
contributing to this present level. Repeat metabolic studies in 
mid-May (to be published in detail elsewhere) will allow 
quantification of the changes in the synthesis and catabolism 
of cholesterol and LDL. 
ADDENDUM 
June 12, 1984: After 6 more weeks offollow-up (total now, 
4 months) the patient remains well with normal cardiac and 
liver function. Plasma cholesterol and triglyceride 
concentrations remain the same as at the time of the report. 
ISOLATION OF HUMAN T-LYMPHOTROPIC 
RETROVIRUS (LAV) FROM ZAIRIAN MARRIED 
COUPLE, ONE WITH AIDS, ONE WITH 
PRODROMES 
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Summary A Zairian married couple had been living in 
France since 1981. The man had acquired 
immunodeficiency syndrome (AIDS) and his wife had 
prodromes of the disorder. Infection with a human 
T-Iymphotropic retrovirus (lymphadenopathy-associated 
virus) was demonstrated in both by isolation of the virus from 
their cultured lymphocytes and the detection of specific 
antibodies in serum samples. Since this virus has been 
isolated from patients in other AIDS risk categories, the 
finding of the virus in AIDS patients from the African group 
adds further support to the hypothesis that this human 
retrovirus is the AIDS aetiological agent. 
INTRODUCTION 
EVIDENCE of a role for retroviruses in acquired 
immunodeficiency syndrome (AIDS) has been supported by 
the isolation of a new human T-Iymphotropic retrovirus 
(lymphadenopathy-associated virus; LA V) from high-risk 
popUlations such as homosexual men with lymphadenopathy 
syndrome l,2 and from AIDS patients2- 4 such as a young 
haemophiliac.5 LAV affects in particular the OKT4-positive 
helper T-Iymphocyte subpopulation3 (and D. Klatzmann et 
aI, unpublished) that is involved in the cellular immune 
deficiency.6,7 Epidemiological surveys on serum antibodies 
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to LAV8,9 also suggest that this virus may have a role in the 
pathogenesis of AIDS. Many cases of this disorder reported 
in Europe since 1983 have been in Black patients from central 
and equatorial Africa lO- 14 or Whites who have travelled in 
this area. II - 15 They have none of the usual risk factors. 
Clearly, the isolation of LAV in AIDS patients from the 
African group, which has geographical, ethnic, and 
epidemiological characteristics distinct from those of the 
other AIDS risk categories, would be strong support for its 
role in the disease. We report here the isolation of an LA V-
related virus from cultured lymphocytes of a Zairian couple 
living in France. The man had AIDS and prodromal 
symptoms were recognised in his wife. 
CASE·REPORTS 
Patient 1 
A 26-year-old Black Zairian man was admitted to the Bid:tre 
hospital in November, 1982, with fever, weight loss, meningeal 
syndrome, hepatomegaly, splenomegaly, and lymphadenopathy. 
He had previously been healthy and denied hll1ilK!zlex~ anddrug 
abuse. He had never received any blood product transfusion. He 
and his wife had come from Zaire to France in 1981 and had not 
returned to Africa since. They had never travelled in the Caribbean 
or in the USA. The patient had oral thrush and condyloma 
acuminata. A herpes simplex homini virus was isolated in cultures 
from a genital ulcer. Severe disseminated cryptococcosis was 
diagnosed on direct examination and cultures of the cerebrospinal 
fluid, lymph-node and bone· marrow aspirates, urine, and liver 
biopsy samples. Examination offaecal samples revealed no parasite. 
He had serum antibodies to herpes simplex virus, cytomegalovirus, 
and Epstein-Barr virus, and markers of hepatitis B infection were 
present (table I). His lymphocytes expressed the HLA DRS 
phenotype. The cryptococcosis was controlled by antifungal agents, 
and the patient was discharged in April, 1983, on oral flucytosine 
and ketoconazole. Recently Mycobacterium kansasii tenosynovitis of 
the hand developed and he remains chronically ill. 
Patient 2 
Patient 1 and his wife, a 23-year-old Black Zairian, had been living 
together since 1980 and had discontinued sexual relations from 




TABLE I-HEPATITIS B MARKERS AND VIRAL SEROLOGY 
Patient I Patient 2 
Nov, 1982, to Jan, 1983 April, 1983 
HBsAg* + 
HBsAb* ± 
HBeAg* + ND 
HBeAb* ND 
HSVt 3200 (IgG) 1600 (IgG) 
CMVt J200 (IgG) 3200 (IgG) 
EEV (IgG only) 
VCA:j: 1280 320 
EA:j: 160 <5 
EBNA§ 320 160 
Results expressed as presence (+), absence (-), or doubtful (±) in serum, or as 
serum antibody titfl'S. HSV= herpl.?s simplex virus; CL\1V ==cytomegalovirus; 
EBV=Epstein-Barr virus; VCA=viral capsid antigl:n; EA=early ,mtigcn; 
EBNA= Epstein-Barr virus nuclear antigen; ND=not done. 
Measured by: *radioimmunoassay; tenzymc-linked immunosorbent assay; 
*indircct immunofluorescence; §anticompkment immunofluorescence 
(Dr De The, Lyon). 
TABLE ll-IMMCNOLOGlCAL bsAiCK~qflk 
Patient 1 Patient 2 
Dec, Nov. April, Feb, 
1982 1983 1983 1984 Normal values· 
-
._---
IgG (gil) 34·4 24·8 7-17 
IgA E~/fF 4· 3b 4·90 0,7-.3,5 
IgM (gil) 2·3 2·24 0·5-3,5 
LympllOcvtcs (X J(ftll) O· 32 0·51 2·08 1·32 1,4-5,0 
OKT3+ (('115(%) 51 38·1 53'8 50 68·89±6·45 
OKT4+ cdls (%) 13 3·08 1· 3 26 42·12±5·84 
OKT8+ cdls (%) 43 44·9 52·2 ~S 33·13±6·6S 
OKT410KT8 0·3 0·07 0·02 0'S7 1·402±0· 25 
B cells (SIg + cells) 35 13·20 16 28 11·7±1·6 
Ill-vitro blJstogenic 
respoJlScs (cpm) 
PHA 17264 ~P J20 - 7S OW, 
Con A .. 21000 23 2641 ~T 708-89 916 
- -
* Range or mean±standard deviation. SIg ~ surface immunoglobulin; 
PHA = phytohaemagglutinin; Con A ~ concanavalin A. 
April, 1983, patient 2 had lost II kg of weight and complained of 
fatigue. She had oral thrush and chronic herpetic ulcers that had 
developed before June, 1982. Both were confirmed by culture. She 
had prurigo, confirmed by a skin biopsy. No parasites were detected 
in the stools. She had serum antibodies against herpes simplex virus, 
cytomegalovirus, and Epstein-Barr virus (table I). Cervical 
lymphadenopathy developed in February, 1984. She refused 
further investigation. 
IMMUNOLOGICAL EVALUATION 
T-cell helper or suppressor-cytotoxic phenotype was 
determined by indirect immunofluorescence with 
monoclonal antibodies (Ortho Pharmaceuticals) and goat 
anti-mouse immunoglobin (Cappel). B cells were counted by 
a fluorescence method with goat anti-human immunoglobin 
F(ab')2 fragments conjugated with fluorescein. 16 Blastogenic 
responses were determined with phytohaemagglutinin 
(Sigma) 20 /-Ig/ml and concanavalin A (Sigma) 5 /-Ig/m1. Each 
experiment was done in parallel with lymphocytes from a 
healthy control from the hospital staff. 
Patient 1 had cutaneous anergy as tested with standard 
tuberculin, candidin intradermal injections, and the 
'Multitest' (Institut Merieux, Lyon, France) which contains 
seven antigens (tetanus, diphtheria, streptococcus, 
tuberculin, candida, trichophyton, and proteus). His serum 
IgG and IgA levels were raised (table II). He had absolute 
lymphopenia with a profound reduction in OKT4-positive 
cells (helper/inducer phenotype)-O· 042 x 109 lIon 
admission gradually falling to 0·003 xl 09 II. The 
OK T 4/0K T8 ratio was O· 3 on admission and fell to 0·02 in 
... ~ g«Dx~D~~«~! .' 
. \ .-'" 
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April, 1983. The' blastogenic response of peripheral blood 
lymphocytes to concanavalin A was greatly impaired. Patient 
2 had cutaneous anergy to tuberculin and the multitest 
antigens. Her serum IgG and IgA levels were also high. Her 
"absolute lymphocyte count was normal but she had 
0'027X 109/1 OKT4-positive cell~ and the OKT4/0KT8 
ratio was 0·02. In October, 1983, this ratio was 0·15. The 
blastogenic responses to phytohaemagglutinin and 
concanavalin A were very low. 
VIRVS ISOLATION 
In November, 1983, T lymphocytes from patient l's 
peripheral blood were cultured as previously described. I" 
Maximum virus production was obtained on day 15 (fig I) as 
measured by reverse transcriptase activity in the cell-free 
supernatant.I,J The virus was propagated on T lymphocytes 
from a normal donor, and a similar pattern of virus 
production was observed. In both cases, the reverse 
transcriptase peak was followed by a fall in cell growth. The 
virus was characterised as LAV by indirect 
immunofluorescence assay;1 the virus-produci~g cells were 
recognised by the serum of the first patient from whom LAV 
was isolated (positive reference serum), I but not by specific 
antibodies to human T-cell leukaemia virus (HTLV) I p24 or 
to HTLV I p19. No antibody to HTLV I p24 or HTLV-
associated membrane antigens could be detected in patient l's 
serum (L. Schaffar). Moreover, an enzyme-linked 
immunosorbent assay,,9 showed that sequential serum 
samples from patient 1 (from November, 1982, to November, 
1983) contained antibodies to LA V but not to HTLV I. These 
results were confirmed by radioimmunoprecipitation assay;1 
LAV p25 was immunoprecipitated by patient I's serum 
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Fig 1-Virus production, measured by reverse transcriptase activity, 
and cellular growth oflymphocytes from patient l. 
